|
Q4 2019
Filed on Jan 30, 2020
|
7,498
|
$32.1 - $36.51
$241K - $274K
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
73,212
|
$26.64 - $28.86
$1.95M - $2.11M
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
10,708
|
$50.01 - $51.33
$536K - $550K
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
600
|
$19.15 - $21.2
$11.5K - $12.7K
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
18,242
|
$13.33 - $14.95
$243K - $273K
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
74,200
|
N/A
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
2,200
|
N/A
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
10,041
|
$16.95 - $25.35
$170K - $255K
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
29,832
|
N/A
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
100
|
$28.58 - $40.88
$2.86K - $4.09K
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
17,050
|
N/A
|
|
|
Q4 2019
Filed on Jan 30, 2020
|
100
|
$14.22 - $23.38
$1.42K - $2.34K
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
12,400
|
N/A
|
|
|
Q2 2019
Filed on Jan 29, 2020
|
500
|
N/A
|
|
|
Q3 2019
Filed on Jan 29, 2020
|
11,900
|
N/A
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
11,060
|
N/A
|
|
|
Q3 2019
Filed on Jan 29, 2020
|
10,000
|
N/A
|
|
|
Q2 2018
Filed on Jan 29, 2020
|
1,000
|
$64.56 - $77.87
$64.6K - $77.9K
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
216
|
N/A
|
|
|
Q3 2018
Filed on Jan 29, 2020
|
1,000
|
N/A
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
16,600
|
$56.09 - $71.2
$931K - $1.18M
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
1,000
|
N/A
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
13,200
|
N/A
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
10,591
|
N/A
|
|
|
Q3 2018
Filed on Jan 29, 2020
|
8,697
|
$21.84 - $26.15
$190K - $227K
|
|
|
Q4 2018
Filed on Jan 29, 2020
|
100
|
$139.79 - $184.45
$14K - $18.4K
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
36,845
|
N/A
|
|
|
Q3 2019
Filed on Jan 29, 2020
|
10,000
|
$25.61 - $29.0
$256K - $290K
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
5,000
|
N/A
|
|
|
Q4 2018
Filed on Jan 29, 2020
|
10,600
|
$6.11 - $12.77
$64.8K - $135K
|
|
|
Q4 2017
Filed on Jan 29, 2020
|
3,813
|
$44.45 - $69.2
$169K - $264K
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
19,430
|
N/A
|
|
|
Q3 2018
Filed on Jan 29, 2020
|
600
|
N/A
|
|
Valeant Pharmaceuticals Intl
|
Q4 2017
Filed on Jan 29, 2020
|
3,000
|
N/A
|
|
|
Q3 2019
Filed on Jan 29, 2020
|
1,000
|
$76.25 - $83.86
$76.3K - $83.9K
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
7,966
|
N/A
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
12,093
|
N/A
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
13,000
|
N/A
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
400
|
$36.93 - $41.9
$14.8K - $16.8K
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
300
|
N/A
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
10,000
|
N/A
|
|
|
Q4 2017
Filed on Jan 29, 2020
|
300
|
$307.64 - $344.58
$92.3K - $103K
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
11,570
|
N/A
|
|
|
Q4 2017
Filed on Jan 29, 2020
|
22,911
|
$18.51 - $22.58
$424K - $517K
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
4,422
|
N/A
|
|
|
Q3 2018
Filed on Jan 29, 2020
|
3,700
|
$64.58 - $69.09
$239K - $256K
|
|
United States Oil Fund LP
|
Q3 2017
Filed on Jan 29, 2020
|
500
|
N/A
|
|
|
Q3 2017
Filed on Jan 29, 2020
|
3,473
|
N/A
|
|
|
Q2 2017
Filed on Jan 29, 2020
|
8,223
|
N/A
|
|
Immune Pharmaceuticals Inc
|
Q2 2017
Filed on Jan 29, 2020
|
10,000
|
N/A
|
|